By Marie Rosenthal
ViiV Healthcare filed a patent infringement suit against Gilead Sciences, Inc. over bictegravir in the United States and Canada.
The U.S. case is filed in the U.S. District Court for the District of Delaware and the patent is U.S. Patent No. 8,129,385. The Canadian case is filed in the Canadian Federal Court in Toronto and the patent is Canadian Patent No. 2,606,282.
ViiV Healthcare, a company specializing in HIV treatments, is majority-owned by GlaxoSmithKline, with